SIGN UP

top stories

Bristol Myers buys out cell therapy partner 2seventy bio

1 hour ago

BioNTech's shares dip after posting lukewarm revenue guidance

13 hours ago

New Flagship startup aims to trailblaze ‘AI science factories’

12 hours ago

Virtual physical therapy startup Hinge Health files to go public

5 hours ago

Latest

Compounders’ motion for preliminary injunction denied in case over tirzepatide shortage

15 hours ago

Emergent sells once-troubled manufacturing site to Indian CDMO

16 hours ago

Beam shares promising first clinical data on gene editing treatment for a lung and liver disease

16 hours ago

#AAD25: What you need to know from Amgen, Bristol Myers, J&J and more

16 hours ago

Exclusive: FDA blocks drug and device reviewers from taking HHS' buyout offer

17 hours ago

Mired in low expectations, Novo braces for upcoming CagriSema head-to-head trial

17 hours ago

see latest stream

People

Jeb Keiper steps down from Nimbus CEO post, business chief to take over

3 days ago

Roche launches new research center with Harvard in Boston area

3 days ago

Live updates: Makary likely a lock for next FDA chief after breezy Senate hearing

4 days ago

Financing

Longtime biotech investor Frazier Life Sciences is raising its latest venture fund

4 days ago

Lilly, Pfizer invest in UK startup's seed round for neurodegeneration protein degraders

5 days ago

Sofinnova Partners raises €1.2B to back another 50 to 60 life sciences startups

Last week

Startups

At $300M Kardigan startup, former MyoKardia team unveils its first drug, and it comes from Ionis

3 days ago

Swiss biotech ends Phase 2 study in Alzheimer's shortly after Lilly and Biogen did the same

6 days ago

ADCs from a decade-old Singapore biotech find new life with $187M

Last week

Deals

Sun Pharma to acquire Checkpoint Therapeutics and its anti-PD-L1 antibody

21 hours ago

Exclusive: Daiichi Sankyo, Johnson & Johnson partner with RNA delivery startup Nosis Bio

21 hours ago

How bluebird's buyout offer went from $100M upfront to $29M

3 days ago

In FocusSee all

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

Last week

Can Bill Anderson save Bayer?

Last week

Will CRISPR matter?

3 weeks ago

Drugmakers seize on biomarkers to test the FDA's rare disease shift

Last month

Endpoints Standouts

How the world's biggest pharma and biotech companies paid their typical worker in 2023

8 months ago

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

8 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

8 months ago

Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?

8 months ago

Peer review See all

Mar

7

Tune’s CEO search ends as John McHutchison takes top spot; More from Pfizer’s leadership makeover

Feb

28

Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves

Feb

21

Merck KGaA tees up changes to leadership team; Ex-CVS Health CEO joins Thermo Fisher’s board

Feb

14

David Schenkein resigns from Agios’ board; Moderna hires Roivant exec as chief marketing officer

Feb

7

Longtime Sandoz exec announces retirement; Lilly appoints head of India

Pharma channel feed

21 hours ago

Mineralys’ Phase 3 blood pressure pill data support potential FDA approval

Topline pivotal data suggest that Mineralys Therapeutics’ experimental hypertension pill is a good prospect not only for approval but also for widespread adoption as a treatment for ...

READ MORE

Start of 2025 comes with generic drug price decreases, several major increases, report finds

3 days ago

FDA approves Neurotech cell therapy to slow a rare degenerative eye disease

3 days ago

latest in Pharma

Bayer eyes capital raise as it grapples with Monsanto cases

3 days ago

J&J axes Phase 3 depression program due to ‘insufficient efficacy’ shortly after Neumora’s study fail

3 days ago

Moderna stands by its Covid vaccine IP after decision axing two patents

4 days ago

Merck KGaA says earlier moves to localize manufacturing help ease Trump tariff impact

4 days ago

No news is good news? Merck KGaA quiet on potential SpringWorks takeover

4 days ago

see latest stories

Marketing channel feed

5 days ago

Novo Nordisk slashes Wegovy price by nearly two-thirds for cash-paying patients

Novo Nordisk cut the price of its weight loss blockbuster Wegovy by nearly two-thirds for certain patients paying outside of insurance, following a similar move by Eli Lilly.

READ MORE

Misleading exhibit booth panel lands NJ drugmaker an untitled letter from FDA

6 days ago

Eli Lilly expands Zepbound single-dose vial options at lower price

Last week

latest in Marketing

J&J's new cancer combo beats AstraZeneca's Tagrisso on survival in lung trial

2 months ago

Drugs are approved — and made available — faster in US than most of EU, data show

2 months ago

Novartis bolsters Fabhalta data in competition with AstraZeneca

3 months ago

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

3 months ago

FDA says Merz's social media promotion with Nate Berkus is 'misleading'

3 months ago

see latest stories

FDA+ channel feed

3 days ago

What the FDA, NIH hearings tell us about drug and health policy under Trump

President Donald Trump's nominees for NIH director and FDA commissioner sailed through their respective confirmation hearings this week, facing few difficult questions and offering few ...

READ MORE

Judge grants new nationwide block on NIH payment cuts

5 days ago

Trump administration reverses lease termination for major FDA quality lab in St. Louis

5 days ago

latest in FDA+

FDA puts BioNTech’s malaria vaccine on clinical hold

5 days ago

DOGE terminates lease on FDA quality lab in St. Louis and 29 other sites

6 days ago

At least eight drugmakers say they will participate in round two of IRA negotiations

Last week

CHMP recommends Regeneron, Novartis drugs that still await FDA approval

Last week

Exclusive: Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

Last week

see latest stories

Manufacturing channel feed

4 days ago

CordenPharma’s €100M investment top-up; Cytiva to lay off 85 staffers

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

READ MORE

Bavarian Nordic CEO says it can take years to move pharma manufacturing to the US

5 days ago

In an unusual move, Lilly seeks pitches from US states for slice of $27B buildout

5 days ago

latest in Manufacturing

Bourla says Pfizer could transfer production to US to sidestep Trump's tariffs

6 days ago

NIH-backed research tries to use stem cells to restore the eye’s outer layer

6 days ago

Merck mulls new site in Delaware; Granules India buys peptide CDMO

Last week

Updated: Lilly joins Trump administration to announce $27B manufacturing commitment

Last week

Ginkgo uncertain over the future of US government funding, stock drops

Last week

see latest stories